Tag: Cancer: Ovarian
Johnson & Johnson Recalls Baby Powder Due to Presence of Asbestos
This is the first time Johnson & Johnson has pulled its baby powder from the market
PARP Inhibitor Slows Progression of Advanced Ovarian Cancer
Veliparib added to chemotherapy, continued as maintenance tx prolongs progression-free survival
PTSD Symptoms Tied to Higher Risk for Ovarian Cancer
Correlation moderately attenuated after adjustment for health and ovarian cancer risk factors
Intrauterine Device Use May Reduce Incidence of Ovarian Cancer
Novel noncontraceptive benefit seen for all intrauterine devices
Focus on Ovarian Cancer Surgical Volume May Not Be Best Metric
Minimum-volume standards could restrict care at many centers with better-than-expected outcomes
American College of Obstetricians and Gynecologists, May 3-6
The 67th Annual Clinical Meeting of the American College of Obstetricians and Gynecologists The annual meeting of the American College of Obstetricians and...
Genetic Testing Underused in Breast, Ovarian Cancer
Pathogenic variants ID'd in 7.8 percent of patients with breast cancer, 14.5 percent with ovarian cancer
Niraparib Extends Time Without Symptoms in Ovarian Cancer
Findings based on phase 3 study of maintenance therapy with PARP inhibitor following treatment
Lymphadenectomy Does Not Up Survival in Advanced Ovarian Cancer
Findings seen after intra-abdominal macroscopically complete resection with normal lymph nodes
U.S. Agencies Probing Johnson & Johnson Over Asbestos in Talc
Company has faced lawsuits linking its body powders with ovarian cancer or mesothelioma
